Glenmark receives approval to market Momate Rhino metered nasal spray in Russia
Glenmark Pharmaceuticals announced that it has received approval from the Ministry of
Healthcare, Russia to market Momate Rhino (Mometasone Furoate 50 mcg) metered nasal spray as
an over]the]counter (OTC) product for the treatment of seasonal and perennial allergic rhinitis in
patients above 18 years of age.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 25 2019 | 9:27 AM IST